NASDAQ:SPRO | EBITDA | Spero Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2025-12-31
Data captured

Historical EBITDA

DateEBITDA
2025-12-31$31.41M
2024-12-31-$21.73M
2024-03-31-$13.98M
2023-12-31$50.57M
2023-03-31-$14.11M
2022-12-31$26.05M
2022-03-31-$30.02M
2021-12-31-$27.31M
2021-03-31-$19.24M
2020-12-31-$18.61M
2020-03-31-$22.63M
2019-12-31-$25.99M
2019-03-31-$5.51M
2018-12-31-$10.95M
2018-03-31-$10.72M
2017-12-31-$13.9M
2017-03-31-$7.51M
2016-12-31-$8.73M

Annual EBITDA

DateEBITDA
2025-12-31$6.31M
2024-12-31-$73.36M
2023-12-31$21.85M
2022-12-31-$41.33M
2021-12-31-$87.33M
2020-12-31-$78.35M
2019-12-31-$62.47M
2018-12-31-$42.4M
2017-12-31-$41.37M
2016-12-31-$32.94M
2015-12-31-$13.32M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.